(Total Views: 684)
Posted On: 11/23/2020 4:35:19 PM
Post# of 153404

I view this amfAR PR quite favorably. These types of indication-specific cooperative agreements will jump-start progress, while providing very good investor optics.
What I don't quite understand is why Dr. Hope Rugo has not been able to contribute a single mTNBC patient to our trial. I realize that's not specifically her job, but I would have thought she'd have a number of patients who could benefit.
What I don't quite understand is why Dr. Hope Rugo has not been able to contribute a single mTNBC patient to our trial. I realize that's not specifically her job, but I would have thought she'd have a number of patients who could benefit.


Scroll down for more posts ▼